Drug Information

Drug General Information
Drug ID
D05RKV
Former ID
DIB012716
Drug Name
Sch-036
Synonyms
Cannabinoid CB2 inverse agonists (immune disorders); Sch-036; Cannabinoid CB2 inverse agonists (immune disorders), Schering-Plough
Indication Immune disorder [ICD10:D80-D89] Investigative [543878]
Company
Schering-Plough Research Institute
Structure
Download
2D MOL

3D MOL
Canonical SMILES
O=S(=O)(C(F)(F)F)NCC1(CCN(S(=O)(=O)c2n(S(=O)(=O)c3ncccc<br />3)c3ccccc3c2)CC1)CCC
Target and Pathway
Target(s) Cannabinoid receptor 2 Target Info Agonist [543878]
KEGG Pathway Neuroactive ligand-receptor interaction
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 543878(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 57).
Ref 543878(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 57).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.